Nisa Investment Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.3K | Buy |
3,815
+870
| +30% | +$4.4K | ﹤0.01% | 1957 |
|
|
2025
Q1 | $15.6K | Buy |
2,945
+459
| +18% | +$2.43K | ﹤0.01% | 1980 |
|
|
2024
Q4 | $16.8K | Buy |
2,486
+158
| +7% | +$1.07K | ﹤0.01% | 1990 |
|
|
2024
Q3 | $15.3K | Buy |
2,328
+303
| +15% | +$2K | ﹤0.01% | 1988 |
|
|
2024
Q2 | $15.2K | Buy |
2,025
+748
| +59% | +$5.61K | ﹤0.01% | 2036 |
|
|
2024
Q1 | $12.7K | Buy |
1,277
+122
| +11% | +$1.22K | ﹤0.01% | 1996 |
|
|
2023
Q4 | $11.4K | Sell |
1,155
-2,865
| -71% | -$28.2K | ﹤0.01% | 2015 |
|
|
2023
Q3 | $30.8K | Sell |
4,020
-20
| -0.5% | -$153 | ﹤0.01% | 1876 |
|
|
2023
Q2 | $30.2K | Sell |
4,040
-46,310
| -92% | -$346K | ﹤0.01% | 1936 |
|
|
2023
Q1 | $336K | Buy |
50,350
+20
| +0% | +$133 | ﹤0.01% | 1180 |
|
|
2022
Q4 | $388K | Sell |
50,330
-54
| -0.1% | -$416 | ﹤0.01% | 1191 |
|
|
2022
Q3 | $536K | Sell |
50,384
-26,996
| -35% | -$287K | ﹤0.01% | 1007 |
|
|
2022
Q2 | $630K | Buy |
77,380
+76,300
| +7,065% | +$621K | 0.01% | 974 |
|
|
2022
Q1 | $8K | Buy |
+1,080
| New | +$8K | ﹤0.01% | 2246 |
|
|
2021
Q4 | – | Sell |
-2,777
| Closed | -$64 | – | 2309 |
|
|
2021
Q3 | $64 | Buy |
+2,777
| New | +$64 | ﹤0.01% | 1868 |
|